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Systemic Lupus Erythematosus: Cardiovascular Pathophysiology
Jennifer L. Mullins, RN, BSN, PCCN
Otterbein University, Westerville, Ohio
Pathophysiological
Disease Process
•
•
Tiffany Kenley (n.d.) Retrieved from
http://slideplayer.com/slide/1427056/

Introduction
•

•

•

Systemic lupus erythematosus (SLE) is
an autoimmune disease potentiating
chronic inflammation throughout the
human body.
“Autoantibodies react with circulating
antigens to form complexes that can
deposit in…kidney[s], brain, heart,
lungs and vasculature” (Turano, 2013,
p. 49).
Gilbert and Ryan (2014) report SLE
predominately affects females
between 20-40 years of age, but can
begin in childhood.

Aim
•
•
•

•

SLE is a multifaceted disease.
The focus of this research is to gain an
understanding of the cardiovascular
implications of SLE.
Mak and Kow (2014) found “lupus
patients older than 35 are >50 times
more likely to develop [cardiovascular
disease] (CVD) than their age and sex
linked counterparts” (p. 1).
Advanced Practice Nurses are essential
to recognizing, screening and managing
care for persons affected with SLE
(Weinstein et al., 2014).

•

•

•

•

SLE activates the immune system
and the complement cascade.
The chronicity of this activation
theoretically contributes to
atherosclerosis (Ammirati et al.,
2014).
“Atherosclerosis is an
inflammatory disease initiated by
dysfunction of the endothelial
cells of the vasculature… resulting
in damage to the endothelial
layer of the arterial wall” (Turano,
2013, p. 49).
Inflammation stimulates
macrophages, cytokines, T cells
and oxidation of low-density
lipoproteins (LDLs)
The cycle continues,
“macrophages release growth
factor that produces collagen
forming a cap [plaque] over the
accumulation of inflammatory
cells, lipids and necrotic tissue”
(Turano, 2013, p. 49).
The obstruction limits blood flow
or can rupture

Signs and Symptoms
•
•
•
•
•
•
•
•
•
•

“Dyspnea
Cough
Fever
Chest pain
Abdominal/flank pain
Skin rash
Decreased urine output
Arthralgia
Elevated C-reactive protein
Anti-ds DNA

•
•
•
•
•
•
•

Elevated troponin 1
Anemia
Proteinuria
Sinus tachycardia
Pericardial effusion
Mitral valve regurgitation
Cardiomegaly” (Chen, Chang,
Hsu, Liao & Chen, 2014, p. 1118).

•

The measurement of increased
endothelial dysfunction from the FMD
correlation may correspond with
increased cardiovascular dysfunction
(Barsalou et al, 2016)
SLE is linked to an increased rate of
hypertension and premature
cardiovascular disease (Gilbert & Ryan,
2014).

SLE (2013). retrieved from: www.med4alcom/2013/05/diagnosis-of-systemic-lupus.html

Underlying Pathophysiology
•
•

•
•

“Endothelial dysfunction leads to atherogenesis
Lack of homeostasis between vasodilation/vasoconstriction may
accelerate vascular damage
Increased thrombosis
Impaired clearance of apoptotic cells
Skewed Th 1 activation
Increased/ changed activation of T cells
B-cell activation
LDL oxidation leads to increased inflammation, plaque formation
of the arterial intima
Increased thrombosis
Pericarditis, myocarditis and endocarditis” (Wigren, Nilsson &
Kaplan, 2015, pp. 497-498).

Significance of Pathophysiology
•

Barsalou et al (2016) found patients with childhood-onset SLE had
a “statistically significant correlation of flow-mediated dilation
(FMD) with disease duration” (p. 241).
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5. Importance of regular exercise
which was reported to show “no
impairment in macro- or
microvascular function…compared
with healthy controls” (Barnes,
Nualnim, Dhindsa, Renzi & Tanaka,
2014, p. 213).

Conclusion

Lupus and the Heart. (2014). Retrieved from:
www.belmarrahealth.com/lupus-andpericarditis-effect-of-lupus-on-heart-health/

•
•
•
•
•
•

What is systemic lupus(2014). Retrieved from:
www.bushelath.com/1000-discovery-what-issystemic-lupus-erythematosus-sle/

•

Implications for Nursing Care
•

Advanced Practice Nurses should
monitor SLE patients:
1 .“Hypertension
2. Heart failure
3. Diabetes mellitus
4. Labs- lipids, serum creatinine,
potassium, proteinuria
5. Echocardiogram” (Tselios,
Koumaras, Urowitz & Gladman, 2014, p. 523)
•

Advanced Practice Nurses should
educate SLE patients regarding
cardiovascular risk factors:
1. “ Control blood pressure
2. Smoking cessation
3. Dietary restriction
4. Use of antihypertensives, statins and low
dose aspirin” (Tselios, Koumaras, Urowitz &
Gladman, 2014, p. 523).
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